Glazer Capital LLC’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Glazer Capital LLC’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-850,590	Closed	-$8.7M	–	366
2023 Q1	$8.7M	Buy	850,590 +22,530	+3%	+$229K	0.48%	57
2022 Q4	$8.32M	Buy	828,060 +382,235	+86%	+$3.81M	0.22%	133
2022 Q3	$4.39M	Buy	445,825 +378,460	+562%	+$3.71M	0.08%	252
2022 Q2	$656K	Buy	67,365 +39,184	+139%	+$383K	0.02%	416
2022 Q1	$274K	Buy	+28,181	New	+$273K	0.01%	400

Glazer Capital LLC's ORIA Position: Q2 2023 in Review

Glazer Capital LLC sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 850,590 shares — an estimated $8.7M sold.

Glazer Capital LLC first reported a position in ORIA in Q1 2022 and held it in 5 quarters. The position peaked at $8.7M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Glazer Capital LLC reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Glazer Capital LLC sold 850,590 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $8.7M.
Glazer Capital LLC first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q1 2022 and held it in 5 quarters.
Glazer Capital LLC's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $8.7M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Glazer Capital LLC's 13F filing for Q2 2023, filed 14 Aug 2023.